Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ORLISTAT USP, with a corresponding US DMF Number 23978.
Remarkably, this DMF maintains an Active status since its submission on July 19, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 12, 2013, and payment made on August 29, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II